Rethinking Dose and Schedule in Targeted Cancer Therapy: Lessons from Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
This story is reported by ASCO Daily News. Read what other outlets are saying below, then open the original report for full details.